AAV6 as an effective gene delivery vector for prolonged transgene expression in intervertebral disc cells in vivo
Intervertebral disc degeneration is the main contributor to low back pain, now the leading cause of disability worldwide. Gene transfer, either in a therapeutic attempt or in basic research to understand the mechanisms of disc degeneration, is a fascinating and promising tool to manipulate the compl...
Main Authors: | Chi Heon Kim, Colleen Oliver, Hamid Dar, Hicham Drissi, Steven M. Presciutti |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2022-07-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304220301665 |
Similar Items
-
Senotherapeutic drugs for human intervertebral disc degeneration and low back pain
by: Hosni Cherif, et al.
Published: (2020-08-01) -
Polymeric hydrogels and decellularized nucleus pulposus extracellular matrix technology for nucleus pulposus repair and regeneration
by: Xuan Peng, et al.
Published: (2023-01-01) -
Cordycepin inhibits LPS-induced inflammatory and matrix degradation in the intervertebral disc
by: Yan Li, et al.
Published: (2016-05-01) -
Cellular senescence – Molecular mechanisms of intervertebral disc degeneration from an immune perspective
by: Chao Song, et al.
Published: (2023-06-01) -
Metabolic Biomarkers Differentiate a Surgical Intervertebral Disc from a Nonsurgical Intervertebral Disc
by: Beata Toczylowska, et al.
Published: (2023-06-01)